Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) FCF Margin (2024 - 2025)

Beta Bionics' FCF Margin history spans 2 years, with the latest figure at 32.78% for Q4 2025.

  • For Q4 2025, FCF Margin rose 3982.0% year-over-year to 32.78%; the TTM value through Dec 2025 reached 56.08%, up 2326.0%, while the annual FY2025 figure was 56.08%, 2326.0% up from the prior year.
  • FCF Margin for Q4 2025 was 32.78% at Beta Bionics, up from 44.11% in the prior quarter.
  • Across five years, FCF Margin topped out at 32.78% in Q4 2025 and bottomed at 115.13% in Q1 2025.